 |
 |
=46rom: Linda Carlton <[log in to unmask]> To: [log in to unmask] Subject: http://ourworld.compuserve.com/homepages/chronicwellness/dhe= a.htm Date: Tue, 17 Jun 1997 01:26:42 -0700 Colloidal DHEA - LiquidLightning DHEA Plus=99 Information Sheet DHEA Quotes , DHEA FAQ's, Colloid FAQ's, Home Page Blood levels of DHEA in men and women peak around the age of 20, and = it is the only hormone that declines in a linear fashion in both sexes. As = such it is one of the most reliable markers of aging. By age 80, blood levels= of DHEA are only 5% of what they were at age 20. You may have read or heard about wild yam supplements or [DHEA= Chart] crystalline sources of DHEA. Both must travel through the digestive system and lose much of their efficacy. Colloidal DHEA is administered sublingually and composed of particles that are ultrafin= e; 0.0001 to 0.001 microns in diameter. This assures the best absorption= and use by the body. These ultrafine particles do not dissolve but remain suspended in a suitable electrically charged liquid (demineralized wa= ter). DHEA is present in ionized form which makes it biologically available= at an instant! DHEA has been shown to be effective against Arteriosclerosis, Cancer,= AIDS, Diabetes, Alzheimer's, Rheumatoid Arthritis, Lupus, Multiple Sclerosi= s, Chronic Fatigue Immune Dysfunction Disease, Parkinson's Disease, and Obesity! An innovative and revolutionary health and wellness company has just introduced a new, colloidal form of DHEA (dehydroepiandrosterone), wh= ich is 5 to 20 times more effective than capsules, pills, tinctures or table= ts! Colloids are composed of particles that are extremely ultrafine and ultralight -- 0.0001 to 0.01 microns in diameter-so as to assure the = best absorption and use by the body. These particles do not dissolve, but = remain suspended in electrically charged demineralized water. Colloidal solu= tions are far superior to capsules since the body must convert crystalline = DHEA to a colloidal state before it can be utilized at the cellular level. In addition, over 50% of the capsule form may be destroyed in the digest= ive tract. Colloidal DHEA is taken sublingually, thereby bypassing the di= gestive tract altogether and assuring optimal absorption into the blood strea= m. Life Extension/Vitality A team of scientists at the University of California, San Diego, has completed a year-long study of the anti-aging effects of DHEA on a gr= oup of 16 middle-aged to elderly people with some intriguing results. The pa= tients who received DHEA reported a 75 percent increase in their overall well-being. Specifically, patients reported an improved ability to co= pe with stress, greater mobility, less joint pain and better quality sleep. T= he DHEA group was also found to have higher concentrations of insulin growth = factor, a compound that spurs the immune system and normally decreases with a= ge. Other studies showed that when DHEA was fed to mice it increased thei= r life expectancy by a third. The mice seemed younger and had a lower incide= nce of the typical diseases of aging. DHEA reduced the risk of breast, colon= , and lung cancer in mice. Other studies have found that DHEA can reduce th= e risk of liver, skin, and lymphatic tissue cancers. Cardiovascular Disease In a 1986 study published in 'The New England Journal of Medicine', researchers at UC San Diego measured DHEA levels in 242 men 50 to 79 = years old, then tracked their health for 12 years. Men whose initial levels= were higher than 140 mcg were less than half as likely to have died of hea= rt disease by the end of the study, even when researchers took into acco= unt such factors as smoking and cholesterol levels. Those with the highes= t levels fared the best: For every 100-point increase, there was a 48% = drop in heart disease risk and a 36% decrease in death by any cause. A 1988 s= tudy was done at John Hopkins in which rabbits with severe atherosclerosis= where treated with DHEA. They had an almost 50% reduction in plaque size. Dr. Barrett-Conner and her researchers concluded that one of DHEA's protective functions may be to inhibit the enzyme glucose-6-phosphate dehydrogenase, which triggers the production of fatty acids and chole= sterol. When DHEA levels fall, the enzyme system accelerates, increasing prod= uction of both fatty acids and cholesterol. This obviously could promote obe= sity and atherosclerosis. Therefore DHEA seems to protect against diabetes= and obesity, and it appears to do so by inhibiting an enzyme (glucose 6 phosphate dehydronase) which limits fat synthesis. It acts as a therm= ostat that regulates the furnace and inhibits the conversion of carbohydrat= es to fat in the body. Breast Cancer In a study of 5,000 women, it was discovered that those with DHEA blo= od levels less that 10% of the normally expected amount for their age gr= oup all developed breast cancer and died of the disease. These women had subn= ormal urinary excretion of DHEA as long as nine years prior to the developm= ent of the disease. Dr. Arthur Schwartz, a researcher at Philadelphia's Temple University= , found that women with breast cancer have lower DHEA levels and concurrent increases of G6PD (glucose 6 phosphate dehydrogenase), which promotes= cancer as well as fat production. Fat Loss "There isn't any question," Schwartz says, "DHEA is a very effective anti-obesity agent." In mice, it gives almost a fifty percent reducti= on in excess fat. In fact, DHEA appears to be the first substance that when laboratory tested, caused the loss of fat (as opposed to mere weight = loss due to the breakdown of primary lean muscle tissue or fluid loss) wit= hout changing eating habits. DHEA increases the body's ability to transfor= m food into energy, and not only burns off excess fat, but prevents fat from accumulating in the first place. In a 1977 study Terrence Yen, a bio-chemist at Eli Lilly, found that = when DHEA is fed to obese mice, their weight drops significantly, even wit= hout any change in diet or exercise. Diabetes A certain inbred strain of mice has a genetic disorder that causes th= em to develop diabetes. Their pancreatic beta cells, those cells in the pan= creas that make insulin, are also spontaneously destroyed during the course= of their lifetime by yeast/fungus. When this strain of mice was given 0.= 4% DHEA in their diet, the diabetes was rapidly reversed and the beta cells w= ere preserved. In a study of other animals without this genetic disorder,= DHEA reduced the severity of diabetes resulting from administering the diabetes-inducing chemical, streptozotocin. Rhematoid Arthritis In a study of 49 postmenopausal women with rheumatoid arthritis, a co= ndition associated with osteoporosis, DHEA levels were significantly lower th= an in healthy controls. DHEA levels were reduced to a greater extent in wom= en taking corticosteroids for their arthritis than in those who were not= . That finding is not surprising since administering these drugs is known to= reduce the levels of adrenal androgens such as DHEA. In this group of 49 wom= en, DHEA levels correlated significantly with bone mineral density of the= neck of the femur ( a bone in the hip) and the spine. The serum level of D= HEA was able to predict bone mineral density, even after corticosteroid thera= py was taken into account. This study suggests that DHEA might be of benefit= to people with rheumatoid arthritis. Supplementing with DHEA might prevent the osteoporosis that so often develops in individuals with rheumatoid arthritis, particularly in th= ose who are taking corticosteroids. In addition, DHEA may impact positively o= n the arthritic process itself. According to Dr. Lamson, who has given DHEA= to several arthritic patients with low serum levels of DHEA, this treatm= ent often relieves pain and morning stiffness, increases strength and red= uces the need for anti-inflammatory medication. In a study of 45 postmenop= ausal women being treated with corticosteroids, administering DHEA resulted= in an increased sense of well-being, with no side effects. Menopause/Osteoporosis It has been shown that menopause is associated with a reduction in DH= EA levels. In one study, the average plasma level of DHEA (ng/100ml) was= 542 in premenopausal women, 197 in postmenopausal women, and only 126 in wom= en whose ovaries had been surgically removed. In a group of women betwee= n the ages of 55 and 85 years, there was a significant correlation between = serum levels of DHEA and bone density of the vertebral spine. In other word= s, women with higher levels of DHEA had greater bone mass than those wit= h lower DHEA levels. Memory Loss Increasing DHEA in elderly patients appears to improve memory functio= n. Research by medical doctor Eugene Roberts of City of Hope Medical Cen= ter conducted on 31 elderly volunteers indicated that the volunteers who = took DHEA experienced less memory loss that volunteers who given a placebo= . At New York University School of Medicine, psychiatrist Kenneth Bonnet r= eported that DHEA replacement therapy on test mice resulted in better memory.= When Dr. Bonnet treated middle aged and old mice with DHEA, their retentio= n and recall skills, which earlier had been much lower that those of young = mice, now increased to the same levels as the young mice. The French endocrinologist, Etienne-Emile Baulieu, inventor of the ab= ortion pill RU 486, is wagering that doses of DHEA will sharpen the mind eve= n as they protect the body. The hormone helps brain cells grow in the lab,= seems to improve rodents' short-term memory, and has even shown some effect= in humans. "We've already seen some correlation between DHEA levels and = mental acuity in older people," says Baulieu. Alzheimer's Disease The Alzheimer's patients studied by Dr. C.R. Merril of the Laboratory= of Biochemical Genetics at the National Institute of Mental Health in Be= thesda, Maryland, showed DHEA levels 48% lower than the control group of non-Alzheimer's patients. We know that DHEA is a precursor building b= lock of estrogen. In April, 1994, 'Prevention Magazine' quoted Annila Paganin= i-Hill, professor of preventive medicine at the University of Southern Califo= rnia, as saying that increased estrogen may be related to a decrease in the= risk of developing Alzheimer's in women. AIDS In the November 1991 issue of 'The Journal of Infectious Disease,' Dr= . William Regelson demonstrated that people with HIV virus do not suffe= r from full-blown AIDS until their adrenal output of DHEA drops. Blood sampl= es from HIV-positive patients at the University of California at San Francisc= o were tested for both DHEA and T-cell levels, the immune cells that are pri= marily affected with AIDS. Men with low levels of DHEA had double the risk o= f full-blown AIDS compared to men with normal DHEA levels. Parkinson's Disease Patients with diseases of the central nervous system such as senility= of Parkinsonism, who have dangerously low serum blood levels of DHEA, ar= e highly responsive to substitution therapy with DHEA. This quite in ke= eping with the latest surgical method of treatment for Parkinson's patients= . Brain surgeons have implanted slices of adrenal gland tissue into the brain= . This transplanted tissue, which is taken from the diseased patient's own a= drenal gland, or from embryonic adrenal tissue, escapes destruction by the i= mmune system, and produces a partial temporary improvement in Parkinson's patients. If DHEA is administered there is considerable improvement i= n Parkinson's patients, without the risk and side effects of brain surg= ery. Author's note: DHEA is produced in the adrenal gland! Lupus (Systemic Lupus Erythematosus) Stanford University Medical Center investigators Ronald F. van Vollen= hoven, M.D., Ph.D., Edgar G. Engleman, M.D., and James L. McGuire, M.D., rep= orted results of their 3-month trial in 28 women with mild to moderate lupu= s in whom DHEA or placebo was added to their usual medical regimen. In each of four outcome measures, patient self-assessment, physician assessment, a composite index of disease activity and prednisone dose= , mean value in women treated with DHEA improved while those on placebo were= stable or worsened. When placebo patients were subsequently given DHEA for t= hree month after the trial, their symptoms improved similarly to those pat= ients who received the treatment during the blinded phase of the trial. The= only side-effect seen more commonly in DHEA-treated patients was acne, whi= ch responded to topical agents. DHEA Quotes , DHEA FAQ's, Colloid FAQ's, Order Form Home Page ---------------------------------------------------------------------= ------- Copyright =A91996-97 by Chronic Wellness International =99 Last Updated 5/10/97